A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies. (Q53057732)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

author name string

M Gotoh

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

S Yoshizawa

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

S Katagiri

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

T Suguro

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

M Asano

5

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

T Kitahara

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

D Akahane

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

S Okabe

8

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

T Tauchi

9

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

Y Ito

10

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

K Ohyashiki

11

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

language of work or name

0 references

publication date

14 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

49

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

955-960

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Reduced-intensity unrelated cord blood transplantation for patients with advanced malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Early immune reaction after reduced-intensity cord-blood transplantation for adult patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Reduced-intensity conditioning and umbilical cord blood transplantation in adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Umbilical cord blood transplantation: the first 25 years and beyond

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Graft failure after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Use of epigenetic modification to induce FOXP3 expression in naïve T cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.66

21 January 2018

Impact of post-transplant imatinib administration on Philadelphia chromosome-positive acute lymphoblastic leukaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Umbilical cord blood transplantation using non-myeloablative conditioning: the Mexican experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24732960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BMT.2014.66

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/24732960

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53057732&oldid=2211964869"